1378 related articles for article (PubMed ID: 15942939)
21. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
22. Genomic rearrangements in MSH2 and MLH1 are rare mutational events in Spanish patients with hereditary nonpolyposis colorectal cancer.
Castellví-Bel S; Castells A; Strunk M; Ferrández A; Piazuelo E; Milà M; Piñol V; Rodríguez-Moranta F; Andreu M; Lanas A; Piqué JM;
Cancer Lett; 2005 Jul; 225(1):93-8. PubMed ID: 16003840
[TBL] [Abstract][Full Text] [Related]
23. Six novel heterozygous MLH1, MSH2, and MSH6 and one homozygous MLH1 germline mutations in hereditary nonpolyposis colorectal cancer.
Rey JM; Noruzinia M; Brouillet JP; Sarda P; Maudelonde T; Pujol P
Cancer Genet Cytogenet; 2004 Dec; 155(2):149-51. PubMed ID: 15571801
[TBL] [Abstract][Full Text] [Related]
24. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer.
Mangold E; Pagenstecher C; Friedl W; Mathiak M; Buettner R; Engel C; Loeffler M; Holinski-Feder E; Müller-Koch Y; Keller G; Schackert HK; Krüger S; Goecke T; Moeslein G; Kloor M; Gebert J; Kunstmann E; Schulmann K; Rüschoff J; Propping P
Int J Cancer; 2005 Sep; 116(5):692-702. PubMed ID: 15849733
[TBL] [Abstract][Full Text] [Related]
25. A modified multiplex PCR assay for detection of large deletions in MSH2 and MLH1.
Wang Y; Friedl W; Sengteller M; Jungck M; Filges I; Propping P; Mangold E
Hum Mutat; 2002 Mar; 19(3):279-86. PubMed ID: 11857745
[TBL] [Abstract][Full Text] [Related]
26. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
[TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
Wagner A; Barrows A; Wijnen JT; van der Klift H; Franken PF; Verkuijlen P; Nakagawa H; Geugien M; Jaghmohan-Changur S; Breukel C; Meijers-Heijboer H; Morreau H; van Puijenbroek M; Burn J; Coronel S; Kinarski Y; Okimoto R; Watson P; Lynch JF; de la Chapelle A; Lynch HT; Fodde R
Am J Hum Genet; 2003 May; 72(5):1088-100. PubMed ID: 12658575
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms.
Yuan ZQ; Gottlieb B; Beitel LK; Wong N; Gordon PH; Wang Q; Puisieux A; Foulkes WD; Trifiro M
Hum Mutat; 2002 Feb; 19(2):108-13. PubMed ID: 11793469
[TBL] [Abstract][Full Text] [Related]
29. Different molecular mechanisms underlie genomic deletions in the MLH1 Gene.
Viel A; Petronzelli F; Della Puppa L; Lucci-Cordisco E; Fornasarig M; Pucciarelli S; Rovella V; Quaia M; Ponz de Leon M; Boiocchi M; Genuardi M
Hum Mutat; 2002 Nov; 20(5):368-74. PubMed ID: 12402334
[TBL] [Abstract][Full Text] [Related]
30. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT
J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610
[TBL] [Abstract][Full Text] [Related]
31. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer.
Casey G; Lindor NM; Papadopoulos N; Thibodeau SN; Moskow J; Steelman S; Buzin CH; Sommer SS; Collins CE; Butz M; Aronson M; Gallinger S; Barker MA; Young JP; Jass JR; Hopper JL; Diep A; Bapat B; Salem M; Seminara D; Haile R;
JAMA; 2005 Feb; 293(7):799-809. PubMed ID: 15713769
[TBL] [Abstract][Full Text] [Related]
32. Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome.
Rahner N; Friedrichs N; Wehner M; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
Acta Oncol; 2007; 46(6):763-9. PubMed ID: 17653898
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques.
Nakagawa H; Hampel H; de la Chapelle A
Hum Mutat; 2003 Sep; 22(3):258. PubMed ID: 12938096
[TBL] [Abstract][Full Text] [Related]
34. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
[TBL] [Abstract][Full Text] [Related]
35. Mutations associated with HNPCC predisposition -- Update of ICG-HNPCC/INSiGHT mutation database.
Peltomäki P; Vasen H
Dis Markers; 2004; 20(4-5):269-76. PubMed ID: 15528792
[TBL] [Abstract][Full Text] [Related]
36. Distinct patterns of germ-line deletions in MLH1 and MSH2: the implication of Alu repetitive element in the genetic etiology of Lynch syndrome (HNPCC).
Li L; McVety S; Younan R; Liang P; Du Sart D; Gordon PH; Hutter P; Hogervorst FB; Chong G; Foulkes WD
Hum Mutat; 2006 Apr; 27(4):388. PubMed ID: 16541406
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis of HNPCC: mutations of MMR genes.
Papadopoulos N; Lindblom A
Hum Mutat; 1997; 10(2):89-99. PubMed ID: 9259192
[TBL] [Abstract][Full Text] [Related]
38. High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country.
Martínez-Bouzas C; Ojembarrena E; Beristain E; Errasti J; Viguera N; Tejada Minguéz MI
Cancer Lett; 2007 Oct; 255(2):295-9. PubMed ID: 17582678
[TBL] [Abstract][Full Text] [Related]
39. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
[TBL] [Abstract][Full Text] [Related]
40. Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer.
Viel A; Genuardi M; Capozzi E; Leonardi F; Bellacosa A; Paravatou-Petsotas M; Pomponi MG; Fornasarig M; Percesepe A; Roncucci L; Tamassia MG; Benatti P; Ponz de Leon M; Valenti A; Covino M; Anti M; Foletto M; Boiocchi M; Neri G
Genes Chromosomes Cancer; 1997 Jan; 18(1):8-18. PubMed ID: 8993976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
